Economic Evaluation of Lipid-Lowering Therapy in the Secondary Prevention Setting in the Philippines

In secondary prevention, simvastatin or pravastatin were the most cost-effective options compared with atorvastatin and gemfibrozil in the Philippines. Gemfibrozil was strongly dominated by the statins.